Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CytoGam infusions at home.

D Hammond1

  • 1Lincolnland Home Care of Sarah Bush Lincoln, Mahoon, IL.

Journal of Intravenous Nursing : the Official Publication of the Intravenous Nurses Society
|June 24, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.

Leukemia & lymphoma·2026
Same author

The effect of branded versus standardized e-cigarette packaging and device designs: an experimental study of youth interest in vaping products.

Public health·2024
Same author

Re: Some weighing of publication rates should be used to more fairly reflect the productivity of trainees. Re: re: Variation in UK Deanery publication rates in the British Journal of Oral and Maxillofacial Surgery: where are the current 'hot spots'?

The British journal of oral & maxillofacial surgery·2021
Same author

Variation in UK Deanery publication rates in the British Journal of Oral and Maxillofacial Surgery: where are the current 'hot spots'?

The British journal of oral & maxillofacial surgery·2020
Same author

Prevalence and pattern of energy drink intake among Australian adolescents.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2020
Same author

Setting up and maximising the usage of an Urgent Dental Care Centre in Blackpool. Sharing our experiences.

The British journal of oral & maxillofacial surgery·2020

CytoGam, a hyperimmune globulin, prevents cytomegalovirus (CMV) infections in organ transplant recipients. Clinical studies show it significantly reduces CMV development, offering hope for immunocompromised patients.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Virology

Background:

  • Cytomegalovirus (CMV) poses a significant risk to organ transplant recipients, particularly when donors are seropositive and recipients are seronegative.
  • Hyperimmune globulin therapies are crucial for preventing opportunistic infections in immunocompromised individuals.

Purpose of the Study:

  • To evaluate the prophylactic efficacy of CytoGam in preventing cytomegalovirus (CMV) infection in seronegative organ transplant recipients receiving organs from CMV-seropositive donors.
  • To assess the role of CytoGam in reducing CMV incidence in patients with human immunodeficiency virus (HIV).

Main Methods:

  • CytoGam, a hyperimmune globulin derived from pooled human plasma rich in CMV antibodies (immunoglobulin G, A, and M), was administered prophylactically.

Related Experiment Videos

  • Clinical studies and trial testing were conducted to assess the impact of CytoGam treatment on CMV development.

    • Main Results:

    • Clinical studies demonstrated a marked decrease in the incidence of cytomegalovirus (CMV) in transplant recipients treated with CytoGam.
    • Trial testing indicated potential for CytoGam in decreasing CMV instances in patients with human immunodeficiency virus (HIV).

    Conclusions:

    • CytoGam is an effective prophylactic agent against cytomegalovirus (CMV) in high-risk organ transplant recipients.
    • The established efficacy and potential for long-term use necessitate home intravenous care for CytoGam therapy.